Genome-wide association and interaction studies of CSF T-tau/Aβ42 ratio in ADNI cohort
Year: 2017
Type: article
Study design: Observational Study
Source: Neurobiology of Aging
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: National Science Foundation, U.S. Department of Defense, Alzheimer's Association, Bristol-Myers Squibb, Alzheimer's Drug Discovery Foundation, Eli Lilly and Company, Pfizer, Merck, Roche, Biogen, AbbVie, F. Hoffmann-La Roche, Medpace, Meso Scale Diagnostics, Alzheimer's Disease Neuroimaging Initiative, BioClinica, Novartis Pharmaceuticals Corporation, Takeda Pharmaceutical Company, Northern California Institute for Research and Education, National Collegiate Athletic Association, National Natural Science Foundation of China, Eisai, Fujirebio Europe, Servier, IXICO, National Institutes of Health, Genentech, GE Healthcare, Canadian Institutes of Health Research, National Key Scientific Instrument and Equipment Development Projects of China, Fundamental Research Funds for the Central Universities, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, U.S. National Library of Medicine, National Center for Advancing Translational Sciences
Awards: G104586243, G1286217783, Indiana Alzheimer Disease Center, Bioinformatics Strategies for Multidimensional Brain Imaging Genetics, III: Small: Collaborative Research: A Large-Scale Data Mining Framework for Genome-Wide Mapping of Multi-Modal Phenotypic Biomarkers and Outcome Prediction, Indiana Clinical and Translational Sciences Institute, G4358867676, Integrative Bioinformatics Approaches to Human Brain Genomics and Connectomics, THE NCAA-DOD GRAND ALLIANCE: CONCUSSION ASSESSMENT, RESEARCH, AND EDUCATION (CARE) CONSORTIUM, EFFECTS OF TRAUMATIC BRAIN INJURY (TBI) AND POST TRAUMATIC STRESS DISORDER (PTSD) ON ALZHEIMER'S DISEASE (AD) IN VETERANS USING IMAGING AND BIOMARKERS IN THE AD NEUROIMAGING INITIATIVE (ADNI)", Alzheimer's Disease Neuroimaging Initiative, Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD, G7280472218, Memory Circuitry in MCI and Early Alzheimerâs Disease Prodrome: Molecular Drivers, Amyloid Imaging, VMCI, and Analysis for ADNI, G8459246291, G9000039018, Alzheimer's Disease Neuroimaging Initiative (ADNI4), G900122319
OpenAlex ID: W2616015692
